AlphaFold predicted structure
PCYT1A · P49585

Mean pLDDT
76.0/ 100
Confident
367 residues
Confidence breakdown
- Very high(≥ 90)50%
- Confident(70–90)20%
- Low(50–70)4%
- Very low(< 50)26%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphate cytidylyltransferase 1A, choline
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalInsulin resistance (including lipodystrophy)
BIALLELIC, autosomal or pseudoautosomalRetinal disorders
BIALLELIC, autosomal or pseudoautosomalSevere insulin resistance and lipodystrophy syndromes
BIALLELIC, autosomal or pseudoautosomalSkeletal dysplasia
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalMonogenic diabetes
BIALLELIC, autosomal or pseudoautosomalSpondylometaphyseal dysplasia - cone-rod dystrophy
spondylometaphyseal dysplasia-cone-rod dystrophy syndrome
lipodystrophy, congenital generalized, type 5
neurodegenerative disease
Leber congenital amaurosis
hereditary disease
cholestasis, progressive familial intrahepatic, 6
congenital generalized lipodystrophy
Insulin resistance
Retinal dystrophy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Choline-phosphate cytidylyltransferase A
Catalyzes the key rate-limiting step in the CDP-choline pathway for phosphatidylcholine biosynthesis
PCYT1A · P49585

Mean pLDDT
76.0/ 100
Confident
367 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0